1 unknown. .
Follow Opal Rheumatology Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents Originator, Biosimilar - Rheumatoid Arthritis, Psoriatic Arthritis | Unknown | Opal Rheumatology Ltd. | 5000 | 2018-03-01 | 2018-03-21 |
Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Spondylitis, Ankylosing (1)
Biosimilar Pharmaceuticals (1) · Etanercept (1) · MIDORI protein, mouse (1)
Australia (1)
Paul Bird (1)